Nurix Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Nurix Therapeutics, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 7 are pending. Notable registered marks include DETIL, NURIX, NXACT, and DELIGASE. The owner is based in San Francisco, CA.
1700 Owens Street, Suite 205
San Francisco, CA 94158
Showing of trademarks Trademarks
Trademark Classifications
Nurix Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Nurix Therapeutics, Inc. have?
Nurix Therapeutics, Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 5 registered, 7 pending, 2 abandoned.
What trademark classes does Nurix Therapeutics, Inc. file in?
Nurix Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nurix Therapeutics, Inc.'s most well-known trademarks?
Nurix Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as DETIL, NURIX, NXACT, and DELIGASE. These are among 5 currently registered trademarks in the portfolio.
What is Nurix Therapeutics, Inc.'s trademark registration success rate?
Nurix Therapeutics, Inc. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 7 applications are pending review.